OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
42
Results
Show all
Save search
Copy query
Show results for
Unknown
(42)
Publication Date
Release Date
2025
(9)
2023
(8)
2019
(7)
2022
(5)
2021
(4)
2024
(3)
2018
(2)
2020
(1)
2017
(1)
2015
(1)
2012
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy.
Not available
S-EPMC6629128
|
biostudies-literature
Cite
Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study.
Not available
S-EPMC10674028
|
biostudies-literature
Cite
Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression.
Not available
S-EPMC10208629
|
biostudies-literature
Cite
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies.
Not available
S-EPMC12375912
|
biostudies-literature
Cite
A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid culture.
Not available
S-EPMC7907272
|
biostudies-literature
Cite
ISM1 protects lung homeostasis via cell-surface GRP78-mediated alveolar macrophage apoptosis.
Not available
S-EPMC8794848
|
biostudies-literature
Cite
Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025.
Not available
S-EPMC12640540
|
biostudies-literature
Cite
A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer.
Not available
S-EPMC12141888
|
biostudies-literature
Cite
Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer.
Not available
S-EPMC12321404
|
biostudies-literature
Cite
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma.
Not available
S-EPMC6546744
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets